Treatment Strategy for Rifampin-Susceptible Tuberculosis
N Engl J Med
.
2023 Jun 15;388(24):2296-2297.
doi: 10.1056/NEJMc2304776.
Authors
William Burman
1
,
Greg J Fox
2
,
C Robert Horsburgh
3
Affiliations
1
Public Health Institute at Denver Health, Denver, CO
[email protected]
.
2
University of Sydney, Sydney, NSW, Australia.
3
Boston University, Boston, MA.
PMID:
37314714
DOI:
10.1056/NEJMc2304776
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Rifampin* / therapeutic use
Tuberculosis* / drug therapy
Substances
Rifampin